Cross Country Healthcare gains on report it likely won't be subject of FTC meeting

21 hours ago 1
Nurse at the hospital putting an IV Drip on a patient

andresr/E+ via Getty Images

Cross Country Healthcare (NASDAQ:CCRN) rose 3.3% after a report that the company's planned sale to Aya Healthcare likely won't be the subject of a Federal Trade Commission meeting next week.

Third-party depositions are still happening in the FTC's review of

Recommended For You

More Trending News

Read Entire Article